Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Cortés Salgado

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Ecancermedicalscience|January 28, 2015
Metronomics for thymic carcinomaJacobo Muñoz Del Toro, Patricia Cortez Castedo, Alfonso Cortés Salgado, et al.
Journal of Neurovirology|November 8, 2022
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemmaBelén Baena-Álvarez, Fernando Rodríguez-Jorge, Álvaro Beltrán-Corbellini, et al.
Case Reports in Oncology|July 6, 2019
Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian CancerEva María Guerra Alía, Cayetano Sempere Ortega, Alfonso Cortés Salgado, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 13, 2026
Assessing platinum response in first-line advanced ovarian cancer: clinical implications and future directionsMaria-Pilar Barretina-Ginesta, Andrés Redondo, Alfonso Cortés-Salgado, et al.
The Journal of Pathology|January 15, 2026
Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classificationSilvia González-Martínez, José Palacios, Irene Carretero-Barrio, et al.
Nutricion Hospitalaria|August 31, 2015
ROLE OF PARENTERAL NUTRITION IN ONCOLOGIC PATIENTS WITH INTESTINAL OCCLUSION AND PERITONEAL CARCINOMATOSISEva Aría Guerra, Alfonso Cortés-Salgado, Raquel Mateo-Lobo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 3, 2026
MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinomaEsther Moreno-Moreno, Tamara Caniego-Casas, Ignacio Ruz-Caracuel, et al.
Gynecologic Oncology|February 13, 2025
HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM studyAlfonso Cortés-Salgado, Esther Moreno-Moreno, Irene Carretero-Barrio, et al.
Cancer Research Communications|September 10, 2025
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuis Manso, Rodrigo Sánchez-Bayona, Juan Antonio Guerra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2019
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast CancerMiguel Quintela-Fandino, Serafín Morales, Alfonso Cortés-Salgado, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Ecancermedicalscience|January 28, 2015
Metronomics for thymic carcinomaJacobo Muñoz Del Toro, Patricia Cortez Castedo, Alfonso Cortés Salgado, et al.
Journal of Neurovirology|November 8, 2022
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemmaBelén Baena-Álvarez, Fernando Rodríguez-Jorge, Álvaro Beltrán-Corbellini, et al.
Case Reports in Oncology|July 6, 2019
Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian CancerEva María Guerra Alía, Cayetano Sempere Ortega, Alfonso Cortés Salgado, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 13, 2026
Assessing platinum response in first-line advanced ovarian cancer: clinical implications and future directionsMaria-Pilar Barretina-Ginesta, Andrés Redondo, Alfonso Cortés-Salgado, et al.
The Journal of Pathology|January 15, 2026
Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classificationSilvia González-Martínez, José Palacios, Irene Carretero-Barrio, et al.
Nutricion Hospitalaria|August 31, 2015
ROLE OF PARENTERAL NUTRITION IN ONCOLOGIC PATIENTS WITH INTESTINAL OCCLUSION AND PERITONEAL CARCINOMATOSISEva Aría Guerra, Alfonso Cortés-Salgado, Raquel Mateo-Lobo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 3, 2026
MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinomaEsther Moreno-Moreno, Tamara Caniego-Casas, Ignacio Ruz-Caracuel, et al.
Gynecologic Oncology|February 13, 2025
HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM studyAlfonso Cortés-Salgado, Esther Moreno-Moreno, Irene Carretero-Barrio, et al.
Cancer Research Communications|September 10, 2025
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuis Manso, Rodrigo Sánchez-Bayona, Juan Antonio Guerra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2019
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast CancerMiguel Quintela-Fandino, Serafín Morales, Alfonso Cortés-Salgado, et al.
Pageof 2